title: Epoetin alfa once weekly improves anemia in HIV/hepatitis C virus-coinfected patients treated with interferon/ribavirin: a randomized controlled trial.
authors: Mark S
authors: MS
authors: Sulkowski
authors: Douglas T
authors: DT
authors: Dieterich
authors: Edmund J
authors: EJ
authors: Bini
authors: Norbert
authors: N
authors: Bräu
authors: Daniel
authors: D
authors: Alvarez
authors: Edwin
authors: E
authors: Dejesus
authors: Gerhard J
authors: GJ
authors: Leitz
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000740:Anemia / Q000139:chemically induced / Q000188:drug therapy*; D000998:Antiviral Agents / Q000009:adverse effects*; D004334:Drug Administration Schedule; D000068817:Epoetin Alfa; D004921:Erythropoietin / Q000627:therapeutic use*; D005260:Female; D015658:HIV Infections / Q000150:complications; D006397:Hematinics / Q000627:therapeutic use*; D006526:Hepatitis C / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D007372:Interferons / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D011788:Quality of Life; D011994:Recombinant Proteins; D012254:Ribavirin / Q000009:adverse effects*
chemical_list: D000998:Antiviral Agents; D006397:Hematinics; D011994:Recombinant Proteins; D004921:Erythropoietin; D012254:Ribavirin; D000068817:Epoetin Alfa; D007372:Interferons